Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356638 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl) tetrahy...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 299 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356641 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356645 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 171 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356661 (1-cyclobutyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 816 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356669 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)imid- az...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 325 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356688 (1-cyclopentyl-3-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 621 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356697 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 833 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356699 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- ethy...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 568 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356919 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 373 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356920 ((S)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 830 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356927 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 52 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356929 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 618 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356948 ((S)-1-((S)-3-(9H- carbazol-9-yl)-2- hydroxy-2- met...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 309 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356949 (4-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.06E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356965 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- meth...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 331 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356967 ((S)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 748 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356970 ((S)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 895 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356976 ((R)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 280 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356977 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-6- meth...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 541 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356981 ((R)-1-((S)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 838 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356983 ((R)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 397 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356984 (1-(3-(9H-carbazol- 9-yl)-2-hydroxy-2- methylpropyl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 523 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356991 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl) pyrroli...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 288 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356633 (1-(3-(9H-carbazol-9-yl)-2-hydroxypropyl)piperidin-...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 171 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356636 (US10214507, Compound 71) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 188 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356646 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 625 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356658 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356676 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 317 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356711 (US10214507, Compound 101) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 417 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356712 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 625 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356719 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 760 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356723 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.22E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356725 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 342 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356726 ((1R,4S)-2-((S)-3- (9H-carbazol-9-yl)- 2-hydroxypro...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 750 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356728 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 484 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356934 ((S)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 188 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356951 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 329 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356979 ((S)-1-((S)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.13E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356639 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 389 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356644 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 719 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356649 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 527 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356659 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356663 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 288 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356671 (US10214507, Compound 85) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 667 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356679 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 547 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356685 (3-cyclohexyl-1-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356698 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.05E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356704 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 422 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356705 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- isop...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 269 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356715 (3-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 940 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356716 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 678 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356717 (US10214507, Compound 104) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 115 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356924 ((S)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 470 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356937 (3-cyclobutyl-1-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 204 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356941 (3-cyclobutyl-1-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.36E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356942 ((R)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 210 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356956 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 716 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356635 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- meth...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 736 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356642 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 536 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356653 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 300 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356654 (1-cyclobutyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 440 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356670 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 463 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356672 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 417 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356683 (3-cyclohexyl-1-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 379 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356694 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 332 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356702 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 824 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356720 ((1R,4S)-2-((R)-3- (3,6-difluoro-9H- carbazol-9-yl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 54 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356724 ((1R,4S)-2-((R)-3- (9H-carbazol-9-yl)- 2-hydroxypro...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 89 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356922 ((R)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 95 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356923 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356925 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.06E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356936 ((R)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356944 ((S)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 263 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356945 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 808 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356946 ((R)-1-((S)-3-(9H- carbazol-9-yl)-2- hydroxy-2- met...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 311 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356973 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-5- meth...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 370 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356988 ((R)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 826 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356992 ((S)-1-((R)-3-(9H- carbaxol-9-yl)-2- hydroxypropyl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 520 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356643 (1-cyclohexyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 284 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356648 (1-cyclopentyl-3-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 609 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356656 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 923 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356665 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 541 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356684 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 438 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356693 (1-cyclopropyl-3-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 527 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356710 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 539 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356721 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 224 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356921 (4-cyclopropyl-1-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 420 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356932 ((R)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 311 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356962 ((S)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxy-2- met...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 172 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356980 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- meth...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 462 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356986 ((S)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.13E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356993 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3,3- di...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 137 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356640 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 192 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356650 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 620 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356668 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 164 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356687 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 261 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356714 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 286 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356930 ((S)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 500 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356940 ((S)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 302 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356947 (4-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 738 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356958 ((R)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxy-2- met...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 535 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356992 ((S)-1-((R)-3-(9H- carbaxol-9-yl)-2- hydroxypropyl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 766 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356660 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 909 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356675 (3-cyclopentyl-1-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 338 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356680 (1-cyclohexyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 310 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356686 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 605 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356695 (1-cyclobutyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 129 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356700 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 478 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356706 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 895 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356707 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- cycl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 555 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356708 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 832 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356709 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- cycl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 721 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356722 ((1S,4R)-2-((R)-3- (9H-carbazol-9-yl)- 2-hydroxypro...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 220 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356729 ((R)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 226 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356926 ((R)-1-((S)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 948 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356928 ((R)-1-(3-(3,6- difluoro-9H- carbazol-9-yl)-2- hydr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 287 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356931 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 299 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356933 (2-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356935 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 137 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356939 (3-cyclobutyl-1-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 265 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356950 ((S)-1-((S)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 451 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356982 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-4- cycl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356987 (1-(3-(9H-carbazol- 9-yl)-2-hydroxy-2- methylpropyl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 225 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356634 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- fluo...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 61 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356655 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 487 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356664 (1-cyclohexyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.19E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356666 (1-cyclopropyl-3-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 147 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356674 (US10214507, Compound 86) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 497 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356691 (3-cyclopentyl-1-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 399 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356696 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 79 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356701 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- cycl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 493 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356703 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- cycl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 315 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356713 (US10214507, Compound 102) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 455 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356938 ((R)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 184 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356943 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.34E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356952 ((R)-1-((S)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 958 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356961 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 986 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356969 (2-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-4- meth...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 710 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
